AU5460800A - Pharmaceutical transdermal compositions - Google Patents

Pharmaceutical transdermal compositions

Info

Publication number
AU5460800A
AU5460800A AU54608/00A AU5460800A AU5460800A AU 5460800 A AU5460800 A AU 5460800A AU 54608/00 A AU54608/00 A AU 54608/00A AU 5460800 A AU5460800 A AU 5460800A AU 5460800 A AU5460800 A AU 5460800A
Authority
AU
Australia
Prior art keywords
transdermal compositions
pharmaceutical transdermal
pharmaceutical
compositions
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54608/00A
Inventor
Vanaja V. Ragavan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aviana BioPharm Inc
Original Assignee
Aviana BioPharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aviana BioPharm Inc filed Critical Aviana BioPharm Inc
Publication of AU5460800A publication Critical patent/AU5460800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU54608/00A 1999-06-02 2000-06-02 Pharmaceutical transdermal compositions Abandoned AU5460800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13718699P 1999-06-02 1999-06-02
US60137186 1999-06-02
PCT/US2000/015289 WO2000072883A2 (en) 1999-06-02 2000-06-02 Pharmaceutical transdermal compositions

Publications (1)

Publication Number Publication Date
AU5460800A true AU5460800A (en) 2000-12-18

Family

ID=22476172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54608/00A Abandoned AU5460800A (en) 1999-06-02 2000-06-02 Pharmaceutical transdermal compositions

Country Status (2)

Country Link
AU (1) AU5460800A (en)
WO (1) WO2000072883A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191090B (en) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
PL367337A1 (en) * 2001-05-31 2005-02-21 Pharmacia Corporation Skin-permeable selective cyclooxygenase-2 inhibitor composition
SE0103528D0 (en) * 2001-10-21 2001-10-21 Jan Faergeman Topical compositions with enhanced effect
AU2002366800B2 (en) 2001-12-20 2006-08-03 Femmepharma Holding Company, Inc. Vaginal delivery of drugs
JP2006515026A (en) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド Pharmaceutical preparations for the treatment of breast diseases and disorders
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
DK1682537T3 (en) 2003-11-05 2012-07-09 Sarcode Bioscience Inc Cell adhesion modulators
AU2005310072B2 (en) 2004-11-29 2011-06-02 Ambria Dermatology Ab A composition comprising at least 3 different diols
US7879344B2 (en) 2006-06-29 2011-02-01 Kimberly-Clark Worldwide, Inc. Transdermal delivery of oleocanthal for relief of inflammation
CA2702984C (en) 2007-10-19 2017-04-11 Sarcode Corporation Compositions and methods for treatment of diabetic retinopathy
EP2147674A1 (en) 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
JP6180930B2 (en) * 2010-06-16 2017-08-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Methods and compositions for stimulating reepithelialization during wound healing processes
US10350223B2 (en) 2015-03-03 2019-07-16 Richard W. Yee Compositions and methods for treating ocular diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
ES2042564T3 (en) * 1986-06-13 1993-12-16 Procter & Gamble COMPOSITIONS BY VIA TOPICA IMPROVED PENETRANTS TO INCREASE HAIR GROWTH.
EP0302147A1 (en) * 1987-08-03 1989-02-08 The Procter & Gamble Company Topical tanning compositions
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
MX9303557A (en) * 1992-08-06 1994-03-31 Beta Pharm Co METHOD FOR ADMINISTRATION OF AN ANTI-ANDROGEN, IN PARTICULAR, SPIRONOLACTONE, THROUGH THE SKIN.
IL124764A0 (en) * 1998-06-04 1999-01-26 Univ Ben Gurion Topical composition for treatment of baldness

Also Published As

Publication number Publication date
WO2000072883A2 (en) 2000-12-07
WO2000072883A3 (en) 2001-08-23
WO2000072883A9 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU1071301A (en) Pharmaceutical compounds
AU3192700A (en) Medicinal compositions
PL351387A1 (en) Pharmaceutical composition
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU3556400A (en) Pharmaceutical compositions
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2005300A (en) Medicinal compositions
GB9923436D0 (en) Pharmaceutical compositions
AU1887401A (en) Medicinal composition
AU4328800A (en) Pharmaceutical formulation
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
AU6715600A (en) Pharmaceutical formulations
AU5460800A (en) Pharmaceutical transdermal compositions
GB9904163D0 (en) Pharmaceutical compositions
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU6460400A (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU4977300A (en) Pharmaceutical formulations
AU6460200A (en) Pharmaceutical compositions
AU5722900A (en) Pharmaceutical compounds
AU1385801A (en) Pharmaceutical formulations
AU7012200A (en) Pharmaceutical compositions comprising 4-quinolones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase